Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Transplantation

  Free Subscription


Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    August 2018
  1. YAMADA N, Katano T, Hirata Y, Okada N, et al
    Serum Mac-2 Binding Protein Glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14438.
    PubMed     Text format     Abstract available


    June 2018
  2. MAHADY SE, Adams LA
    Burden of non-alcoholic fatty liver disease in Australia.
    J Gastroenterol Hepatol. 2018;33 Suppl 1:1-11.
    PubMed     Text format     Abstract available


    January 2018
  3. HARIMOTO N, Yugawa K, Ikegami T, Ohira M, et al
    Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.
    J Gastroenterol Hepatol. 2018;33:9.
    PubMed     Text format    


    December 2017
  4. CHOUDHURY A, Kumar M, Sharma BC, Maiwall R, et al
    Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.
    J Gastroenterol Hepatol. 2017;32:1989-1997.
    PubMed     Text format     Abstract available


    July 2017
  5. CHINNARATHA MA, Kaambwa B, Woodman RJ, Fraser RJ, et al
    Assessing the clinical and economic impact of increasing treatment uptake in chronic hepatitis B infection using a Markov model.
    J Gastroenterol Hepatol. 2017;32:1370-1377.
    PubMed     Text format     Abstract available


    June 2017
  6. ZHANG X, Li J, Shen F, Lau WY, et al
    Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Jun 6. doi: 10.1111/jgh.13843.
    PubMed     Text format     Abstract available


  7. CHAN HL, Tsang OT, Hui YT, Fung J, et al
    Real-life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong.
    J Gastroenterol Hepatol. 2017;32:1230-1233.
    PubMed     Text format     Abstract available


    February 2017
  8. KIRSTEIN MM, Schweitzer N, Winter T, Lappas K, et al
    Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma -experience from a referral center.
    J Gastroenterol Hepatol. 2017 Feb 10. doi: 10.1111/jgh.13761.
    PubMed     Text format     Abstract available


    January 2017
  9. SI T, Chen Y, Ma D, Gong X, et al
    Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: a meta-analysis.
    J Gastroenterol Hepatol. 2017 Jan 13. doi: 10.1111/jgh.13727.
    PubMed     Text format     Abstract available


    October 2016
  10. QU Y, Guo Y, Li T, Ye Q, et al
    Efficacy and Safety of Sofosbuvir-based Interferon-free Therapies for Hepatitis C in Liver Transplant Recipients.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13614.
    PubMed     Text format     Abstract available


  11. DEL BELLO A, Danjoux M, Congy-Jolivet N, Lavayssiere L, et al
    Histological long-term outcomes from acute antibody-mediated rejection following ABO-compatible liver transplantation.
    J Gastroenterol Hepatol. 2016 Oct 14. doi: 10.1111/jgh.13613.
    PubMed     Text format     Abstract available


    October 2015
  12. BALDUCCI G, Sterpetti AV, Ventura M
    A short history of portal hypertension and of its management.
    J Gastroenterol Hepatol. 2015 Oct 29. doi: 10.1111/jgh.13200.
    PubMed     Text format     Abstract available


    July 2015
  13. NGUYEN BD
    Post-transplant recurrence of fibrolamellar hepatocellular carcinoma in lung and pancreas.
    J Gastroenterol Hepatol. 2015 Jul 30. doi: 10.1111/jgh.13048.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: